Source: Eur Respir J, 51 (6) 1800467; 10.1183/13993003.00467-2018
Disease area: Pulmonary vascular diseases



Rating:

Share or cite this content

Citations should be made in the following way:
Grayson L. Baird, Christine Archer-Chicko, R. Graham Barr, David A. Bluemke, Andrew E. Foderaro, Jason S. Fritz, Nicholas S. Hill, Steven M. Kawut, James R. Klinger, Joao A.C. Lima, Christopher J. Mullin, Pamela Ouyang, Harold I. Palevsky, Amy J. Palmisicano, Diane Pinder, Ioana R. Preston, Kari E. Roberts, K. Akaya Smith, Thomas Walsh, Mary Whittenhall, Corey E. Ventetuolo. Lower DHEA-S levels predict disease and worse outcomes in post-menopausal women with idiopathic, connective tissue disease- and congenital heart disease-associated pulmonary arterial hypertension. Eur Respir J, 51 (6) 1800467; 10.1183/13993003.00467-2018

Member's Comments

No comment yet.

Related content which might interest you: Early risk prediction in idiopathic versus connective tissue disease-associated pulmonary arterial hypertension: call for a refined assessment Source: ERJ Open Res, 7 (3) 00854-2020; 10.1183/23120541.00854-2020 Year: 2021 Age, risk and outcomes in idiopathic pulmonary arterial hypertension Source: Eur Respir J, 51 (5) 1800629; 10.1183/13993003.00629-2018 Year: 2018 Tadalafil in idiopathic or heritable pulmonary arterial hypertension compared to pulmonary arterial hypertension associated with connective tissue disease Source: Annual Congress 2011 - Treatment of human pulmonary hypertension Year: 2011 Initial experience of sildenafil in patients with congenital heart disease (CHD) associated pulmonary arterial hypertension (PAH) Source: Eur Respir J 2006; 28: Suppl. 50, 425s Year: 2006 Connective tissue disease associated with pulmonary arterial hypertension: management of a patient with severe haemodynamic impairment Source: Eur Respir Rev 2014; 23: 505-509 Year: 2014 Characteristics of patients with pulmonary arterial hypertension associated with congenital heart disease in the French PAH registry Source: Annual Congress 2011 - Clinical characteristics of patients with pulmonary hypertension Year: 2011 Double combination therapy in patients with pulmonary arterial hypertension associated with connective tissue disease Source: Annual Congress 2011 - Treatment of human pulmonary hypertension Year: 2011 Pulmonary arterial hypertension in paediatric and adult patients with congenital heart disease Source: Eur Respir Rev 2009; 18: 154-161 Year: 2009 Social deprivation in Scottish populations with pulmonary hypertension secondary to connective tissue disease and chronic thromboembolic disease Source: ERJ Open Res, 6 (4) 00297-2019; 10.1183/23120541.00297-2019 Year: 2020 Autoantibodies are frequently found in arterial and chronic thrombotic pulmonary hypertension not associated to connective tissue diseases Source: Annual Congress 2009 - Pulmonary vascular diseases Year: 2009 Does left heart disease cause most systemic sclerosis associated pulmonary hypertension? Source: Eur Respir J 2013; 42: 888-890 Year: 2013 Changing demographics of pulmonary arterial hypertension in congenital heart disease Source: Eur Respir Rev 2010 19: 308-313 Year: 2010 Reduced pulmonary function is associated with aortic stiffness in men free of cardiovascular diseases Source: Eur Respir J 2002; 20: Suppl. 38, 516s Year: 2002 Effect of sitaxentan in patients with pulmonary arterial hypertension associated to congenital heart diseases Source: Annual Congress 2009 - Pulmonary vascular diseases Year: 2009 Characteristics of idiopathic pulmonary arterial hypertension (IPAH) and PAH associated with connective tissue disease (APAH-CTD) patients in PROSPECT Source: Annual Congress 2013 –Pulmonary circulation: clinical science and treatment Year: 2013 Risk stratification of pulmonary arterial hypertension (PAH) associated with adult congenital heart disease (ACHD) Source: International Congress 2019 – Endpoints and risk assessment of pulmonary arterial hypertension Year: 2019 Borderline pulmonary hypertension was associated with reduced cardiac output during exercise in patients withconnective tissue diseases Source: International Congress 2017 – Exercise and physiology in pulmonary hypertension Year: 2017 Usefulness of differential blood gas exchange assessment in patients with severe pulmonary arterial hypertension (PAH) associated to congenital heart disease (CHD) Source: Eur Respir J 2005; 26: Suppl. 49, 351s Year: 2005 1 year evolution of pulmonary hypertension in patients with connective tissue diseases and secondary antiphospholipid syndrome Source: Eur Respir J 2004; 24: Suppl. 48, 280s Year: 2004 Incidence of new pulmonary hypertension and determining factors during follow-up of patients with systemic sclerosis after negative right heart catheterisation Source: International Congress 2017 – PAH and CTEPH Year: 2017